Epstein-Barr Virus Antibody to Viral Capsid Antigen, IgA
0051626
 
Ordering Recommendation
Do not use to diagnose Epstein-Barr virus infectious mononucleosis. May aid in the detection and prognosis of nasopharyngeal carcinoma.
Mnemonic
EBV A
Methodology
Semi-Quantitative Enzyme-Linked Immunosorbent Assay
Performed
Tue
Reported
1-8 days
New York DOH Approval Status
This test is New York DOH approved.
Specimen Required
Patient Preparation
 
Collect
Serum separator tube.  
Specimen Preparation
Separate serum from cells ASAP or within 2 hours of collection. Transfer 0.5 mL serum to an ARUP Standard Transport Tube. (Min: 0.1 mL) Parallel testing is preferred and convalescent specimens must be received within 30 days from receipt of the acute specimens. Mark specimen plainly as "acute" or "convalescent."  
Storage/Transport Temperature
Refrigerated.  
Unacceptable Conditions
Contaminated or heat-inactivated specimens.  
Remarks
 
Stability
After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year  
Reference Interval
Effective February 19, 2013

0.79 U/mL or less: Not Detected
0.80 - 1.20 U/mL: Indeterminate. Repeat testing in 10-14 days may be helpful.
1.21 U/mL or greater: Detected
Interpretive Data


See Compliance Statement D: www.aruplab.com/CS
Note
CPT Code(s)
86665
Components
Component Test Code*Component Chart Name
0051626EBV Antibody To Viral Capsid Antigen IgA
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, contact interface support at interface.support@aruplab.com.
Cross References
  • EBV Antibodies
  • EBV VCA-IgA Ab
  • Infectious Mononucleosis